50 Mg Decitabine For Injection
50 Mg Decitabine For Injection

50 Mg Decitabine For Injection

Price 8000 INR/ Vial

MOQ : 5 Vials

50 Mg Decitabine For Injection Specification

  • Pacakaging (Quantity Per Box)
  • 1 Vial per Box
  • Indication
  • Myelodysplastic Syndromes, Acute Myeloid Leukemia
  • Origin of Medicine
  • Imported / Allopathic
  • Salt Composition
  • Decitabine 50 mg
  • Dosage Form
  • Lyophilized Powder for Injection
  • Drug Type
  • Prescription
  • Ingredients
  • Decitabine
  • Physical Form
  • Powder for Injection
  • Function
  • Anticancer (Antineoplastic Agent)
  • Recommended For
  • Treatment of Myelodysplastic Syndromes, Acute Myeloid Leukemia
  • Dosage
  • As prescribed by the physician
  • Dosage Guidelines
  • Administer intravenously. Refer to physician directions.
  • Suitable For
  • Adults
  • Quantity
  • 50 mg per vial
  • Storage Instructions
  • Store below 25C. Protect from light. Do not freeze.
 
 

About 50 Mg Decitabine For Injection



Decilam 50 is a top-rated, superlative lyophilized powder for injection containing Decitabine 50 mg, designed for intravenous infusion. Popular among healthcare professionals for its extraordinary efficacy in treating Myelodysplastic Syndromes and Acute Myeloid Leukemia, Decilam 50 stands out through customizable patient dosing, ensuring sublime therapeutic precision. Manufactured by Laminar Pharmaceuticals and imported as an allopathic formulation, this prescription drug is packed in a glass vial with flip-off seal, assuring safety and convenience. Each vial, suitable for adults, must be reconstituted with 10 ml sterile water prior to use and administered strictly under medical supervision. Shelf life is 24 months. Always store below 25C, protected from light, and never freeze.

Diverse Application Areas of Decilam 50

Decilam 50 Mg Decitabine For Injection is primarily employed in clinical oncology centers for treating Myelodysplastic Syndromes and Acute Myeloid Leukemia. Its extraordinary antineoplastic function holds significant value in specialist hospitals, research institues involved in hematologic disorders, and other advanced medical facilities requiring customizable cancer care solutions. The product's superlative therapeutic profile supports various plant applications related to pharmaceutical compounding and drug development, making it suitable for both institutional and clinical practice environments.


Sample Availability & Market Value Advantages

Samples of 50 Mg Decitabine For Injection, Decilam 50, are available to eligible healthcare facilities at the lowest price, reflecting its remarkable market value. Delivery time is prompt, helping distributors and suppliers meet demand efficiently across India's main domestic market. There is minimal charge for sample procurement, ensuring accessibility for traders, exporters, and suppliers seeking to evaluate product quality prior to full purchase. Laminar Pharmaceuticals ensures secure packing and streamlined logistics throughout the process.


FAQ's of 50 Mg Decitabine For Injection:


Q: How should Decilam 50 be reconstituted before intravenous administration?

A: Decilam 50 must be reconstituted using 10 ml of sterile water for injection. Once dissolved, it should be administered as an intravenous infusion under medical supervision.

Q: What are the main indications for Decitabine 50 mg injection?

A: The main indications include treatment of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) in adult patients, as prescribed by a physician.

Q: Where can Decilam 50 Mg Decitabine For Injection be used?

A: Decilam 50 is suitable for use in hospitals, oncology clinics, and advanced medical institutions specializing in hematologic cancers and related research.

Q: What precautions should be followed during Decilam 50 administration?

A: Decilam 50 is intended for single-use only and must be administered by qualified medical personnel. Use strict aseptic techniques, monitor patient closely during infusion, and store below 25C, protected from light.

Q: How does the product's packaging ensure safety and convenience?

A: Each Decilam 50 vial is packed in a glass vial with a flip-off seal, placed inside a secure carton box. This packaging maintains drug integrity, minimizes contamination risks, and facilitates easy handling in medical settings.

Q: What benefits are provided by the customizable dosing of Decilam 50?

A: Customizable dosing allows physicians to tailor the dosage according to specific patient needs and clinical protocols, leading to extraordinary precision in cancer management and optimizing therapeutic outcomes.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Injection Category

Denosumab Solution For Injection

Denosumab Solution For Injection

Price 21999 INR / Vial

Minimum Order Quantity : 1 Vial

Suitable For : Adults

Pacakaging (Quantity Per Box) : Single vial per box

Indication : Treatment of osteoporosis and bone loss

Origin of Medicine : Allopathic

4000 IU-Ml Erythropoietin Injection BP

4000 IU-Ml Erythropoietin Injection BP

Price 340 INR / Pack

Minimum Order Quantity : 1 Pack

Suitable For : Other, Adults and pediatric patients as advised by a physician

Pacakaging (Quantity Per Box) : 1 prefilled syringe per box

Indication : Treatment of anemia associated with chronic renal failure, chemotherapy, or HIV therapy

Origin of Medicine : Biotechnological origin

50 Mg Dasatinib Tablets

50 Mg Dasatinib Tablets

Price 2500 INR / Box

Minimum Order Quantity : 1 Box

Suitable For : Adults

Pacakaging (Quantity Per Box) : 60 tablets

Indication : Treatment of chronic myeloid leukemia, acute lymphoblastic leukemia (Ph+)

Origin of Medicine : Allopathic

120 Mg Denosumab Injection

120 Mg Denosumab Injection

Price 15000 INR / Vial

Minimum Order Quantity : 1 Vial

Suitable For : Adults

Pacakaging (Quantity Per Box) : Single prefilled syringe in one box

Indication : Prevention of skeletalrelated events in patients with bone metastases, treatment of osteoporosis in postmenopausal women and men at increased risk of fracture

Origin of Medicine : Biological



Back to top